Prevalence of Hepatitis B and C in Patients of Thalassemia in Sargodha, Pakistan
DOI:
https://doi.org/10.53350/pjmhs20221611161Abstract
Background: Thalassemia is one of the commonest genetic hematological disorders and a health issue of global concern. Because of repeated blood transfusions, ratio of hepatitis B and C positivity is escalating in these patients day by day who have further complicated the situation in the form of poor treatment outcomes and costs to individuals
Aim: To measure the prevalence of hepatitis B and C among patients of thalassemia major in Sargodha, Pakistan.
Study design: Cross-sectional study
Place and duration of study: Rai Hospital & Hilal-e-Ahmar Hospital, Sargodha from 01-01-20221 to 31-12- 2021.
Methodology: Three hundred and sixty thalassemia major patients, both beta and alpha, confirmed on hemoglobin electrophoresis admitted in the hospital were enrolled.
Results: The mean age of the participants was 10.24±2.5 years, and 50% were male and 50% females. About 34% of the patients had hepatitis in which 30% had hepatitis C and 1.1% hepatitis B. 2.2% had both.
Conclusion: Hepatitis b and C are highly prevalent among patients of thalassemia major. This also calls physicians, hematologists, pediatricians and policy makers to focus on counseling and support of thalassemia patients by providing them safe blood.
Keywords: Prevalence, Hepatitis B and C, Thalassemia major, Blood transfusion
Downloads
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
